OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
HUNNYSE67

Huntsman CORP

Diversified ChemicalsVerified

Huntsman's capital structure shows a debt-to-equity ratio of 0.77, indicating moderate leverage. The company's liquidity position is characterized by a current ratio of 1.27, suggesting it can cover short-term obligations but with limited buffer. Free cash flow is negative at -$91 million, and operating cash flow is also negative at -$53 million, signaling cash flow constraints. The company's cash and equivalents of $369 million are insufficient to cover total debt of $2.06 billion, resulting in a net cash deficit. Profitability metrics are weak, with a return on equity of -1.98% and a return on assets of -0.74%. These figures fall below the industry median for Diversified Chemicals, which typically sees ROE and ROA in the positive range. Operating income was -$16 million in Q1 2026, and net income was -$53 million, indicating a significant decline in profitability compared to prior periods. Geographically, Huntsman's revenue is concentrated in North America, with a smaller portion derived from Asia and Europe. The Polyurethanes segment is the largest contributor to revenue, followed by Performance Products and Advanced Materials. However, the company has not disclosed specific revenue percentages for each segment, making it difficult to assess the degree of concentration risk. The company's growth trajectory is mixed. Revenue in Q1 2026 was $1.42 billion, but the outlook for the current fiscal year is uncertain due to weak operating performance. Capital expenditures were $38 million, suggesting limited investment in growth. The company's adjusted EBITDA is a key metric for performance tracking, but the lack of recent growth in this metric indicates a challenging operating environment. Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's debt load and negative cash flows increase the risk of financial distress. Additionally, the company's exposure to global markets and the chemical industry's cyclical nature pose operational risks. The risk assessment indicates a medium liquidity risk, with a key flag noting that net cash is negative after subtracting total debt. Recent events include the backfilling of accounts payable data in the latest filing, which may improve transparency. The company has also provided detailed definitions for adjusted EBITDA and other non-GAAP measures, which are used to assess segment performance. These adjustments include the exclusion of restructuring costs, legal settlements, and other non-recurring items, which may affect the comparability of financial results across periods.

30-day price · HUN+2.30 (+20.2%)
Low$10.76High$15.90Close$13.71As of18 May, 00:00 UTC
Profile
CompanyHuntsman CORP
ExchangeNYSE
TickerHUN
CIK0001307954
SICChemicals & Allied Products
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryDiversified Chemicals
AI analysis

Business. Huntsman Corporation is a manufacturer of diversified organic chemical products, operating through three segments: Polyurethanes, Performance Products, and Advanced Materials, and generates revenue primarily from industrial and building product manufacturers.

Classification. Huntsman is classified in the Basic Materials economic sector, Chemicals business sector, and Diversified Chemicals industry with a confidence level of 0.92.

Huntsman's capital structure shows a debt-to-equity ratio of 0.77, indicating moderate leverage. The company's liquidity position is characterized by a current ratio of 1.27, suggesting it can cover short-term obligations but with limited buffer. Free cash flow is negative at -$91 million, and operating cash flow is also negative at -$53 million, signaling cash flow constraints. The company's cash and equivalents of $369 million are insufficient to cover total debt of $2.06 billion, resulting in a net cash deficit. Profitability metrics are weak, with a return on equity of -1.98% and a return on assets of -0.74%. These figures fall below the industry median for Diversified Chemicals, which typically sees ROE and ROA in the positive range. Operating income was -$16 million in Q1 2026, and net income was -$53 million, indicating a significant decline in profitability compared to prior periods. Geographically, Huntsman's revenue is concentrated in North America, with a smaller portion derived from Asia and Europe. The Polyurethanes segment is the largest contributor to revenue, followed by Performance Products and Advanced Materials. However, the company has not disclosed specific revenue percentages for each segment, making it difficult to assess the degree of concentration risk. The company's growth trajectory is mixed. Revenue in Q1 2026 was $1.42 billion, but the outlook for the current fiscal year is uncertain due to weak operating performance. Capital expenditures were $38 million, suggesting limited investment in growth. The company's adjusted EBITDA is a key metric for performance tracking, but the lack of recent growth in this metric indicates a challenging operating environment. Risk factors include liquidity constraints and the potential for dilution, although the risk of dilution is currently assessed as low. The company's debt load and negative cash flows increase the risk of financial distress. Additionally, the company's exposure to global markets and the chemical industry's cyclical nature pose operational risks. The risk assessment indicates a medium liquidity risk, with a key flag noting that net cash is negative after subtracting total debt. Recent events include the backfilling of accounts payable data in the latest filing, which may improve transparency. The company has also provided detailed definitions for adjusted EBITDA and other non-GAAP measures, which are used to assess segment performance. These adjustments include the exclusion of restructuring costs, legal settlements, and other non-recurring items, which may affect the comparability of financial results across periods.
Key takeaways
  • Huntsman's liquidity position is weak, with a current ratio of 1.27 and negative free cash flow.
  • Profitability metrics are negative, with ROE and ROA below industry medians.
  • Revenue is concentrated in the Polyurethanes segment, with limited geographic diversification.
  • Growth is constrained by weak operating performance and limited capital expenditures.
  • The company faces liquidity and operational risks due to its debt load and exposure to cyclical markets.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodQ1 2026
CurrencyUSD
Revenue$1.42B
Gross profit$183.0M
Operating income-$16.0M
Net income-$53.0M
R&D$29.0M
SG&A
D&A$73.0M
SBC$9.0M
Operating cash flow-$53.0M
CapEx$38.0M
Free cash flow-$91.0M
Total assets$7.13B
Total liabilities$4.23B
Total equity$2.68B
Cash & equivalents$369.0M
Long-term debt$1.68B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY2024$5.68B-$131.0M-$284.0M$116.0M
FY2024$6.04B-$25.0M-$189.0M$79.0M
FY2023$6.11B$84.0M$101.0M-$21.0M
FY2024$6.11B$84.0M$101.0M-$21.0M
FY2022$8.02B$672.0M$460.0M$642.0M
PeriodGross %Op %Net %FCF %
FY2024
FY2024
FY2023
FY2024
FY2022
PeriodAssetsEquityCashDebt
FY2024$7.01B$2.75B$429.0M
FY2024$7.11B$2.96B$340.0M
FY2023$7.25B$3.25B$540.0M
FY2024$7.25B$3.25B$540.0M
FY2022$8.22B$3.62B$654.0M
PeriodOCFCapExFCFSBC
FY2024$289.0M$173.0M$116.0M$31.0M
FY2024$263.0M$184.0M$79.0M$30.0M
FY2023$209.0M$230.0M-$21.0M$28.0M
FY2024$209.0M$230.0M-$21.0M$28.0M
FY2022$914.0M$272.0M$642.0M$29.0M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
Q1 2026$1.42B-$16.0M-$53.0M-$91.0M
Q1 2026
Q3 2025$4.33B-$72.0M-$188.0M$97.0M
Q2 2025$2.87B-$78.0M-$163.0M-$56.0M
PeriodGross %Op %Net %FCF %
Q1 2026
Q1 2026
Q3 2025
Q2 2025
PeriodAssetsEquityCashDebt
Q1 2026$7.13B$2.68B$369.0M
Q1 2026$7.01B$2.75B$429.0M
Q3 2025$7.08B$2.77B$468.0M
Q2 2025$7.15B$2.83B$399.0M
PeriodOCFCapExFCFSBC
Q1 2026-$53.0M$38.0M-$91.0M$9.0M
Q1 2026
Q3 2025$213.0M$116.0M$97.0M$23.0M
Q2 2025$17.0M$73.0M-$56.0M$16.0M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$1.98B
Net cash-$1.69B
Current ratio1.3
Debt/Equity0.8
ROA-0.7%
ROE-2.0%
Cash conversion1.0%
CapEx/Revenue2.7%
SBC/Revenue0.6%
Asset intensity0.3
Dilution ratio-0.2%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Diversified Chemicals · cohort 80 companies
MetricHUNActivity
Op margin-1.1%-1.1% medp25 -1.1% · p75 -1.1%top quartile
Net margin-3.7%-6.6% medp25 -6.6% · p75 -6.6%top quartile
Gross margin12.9%12.9% medp25 12.9% · p75 12.9%bottom quartile
R&D / revenue2.0%1.9% medp25 1.9% · p75 1.9%top quartile
CapEx / revenue2.7%-7.1% medp25 -12.7% · p75 -4.4%top quartile
Debt / equity77.0%1639.6% medp25 1639.6% · p75 1639.6%bottom quartile
Observations
IR observations
market data ESG controversies score100.0
market data ESG governance pillar71.6
market data ESG social pillar67.7
market data insider trading score8.0
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
SEC filingstype companyfacts · CIK 0001307954 · 542 us-gaap concepts
2026-05-01 16:13 UTC#62503e55
Source: analysis-pipeline (hybrid)Generated: 2026-05-01 16:16 UTCJob: 6cdbb7fb